ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $878.66 million. The enterprise value is $683.65 million.

Market Cap	878.66M
Enterprise Value	683.65M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

ORIC has 85.22 million shares outstanding. The number of shares has increased by 23.91% in one year.

Current Share Class	85.22M
Shares Outstanding	85.22M
Shares Change (YoY)	+23.91%
Shares Change (QoQ)	+0.55%
Owned by Insiders (%)	1.67%
Owned by Institutions (%)	74.88%
Float	55.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.98
P/TBV Ratio	4.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.00, with a Debt / Equity ratio of 0.04.

Current Ratio	12.00
Quick Ratio	11.56
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.45% and return on invested capital (ROIC) is -32.34%.

Return on Equity (ROE)	-48.45%
Return on Assets (ROA)	-30.87%
Return on Invested Capital (ROIC)	-32.34%
Return on Capital Employed (ROCE)	-65.10%
Revenue Per Employee	n/a
Profits Per Employee	-$1.16M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.51% in the last 52 weeks. The beta is 1.48, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	+55.51%
50-Day Moving Average	7.03
200-Day Moving Average	8.36
Relative Strength Index (RSI)	68.68
Average Volume (20 Days)	1,461,293

Short Selling Information

The latest short interest is 12.71 million, so 14.92% of the outstanding shares have been sold short.

Short Interest	12.71M
Short Previous Month	13.35M
Short % of Shares Out	14.92%
Short % of Float	22.92%
Short Ratio (days to cover)	6.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-146.62M
Pretax Income	-101.76M
Net Income	-132.86M
EBITDA	-145.48M
EBIT	-146.62M
Earnings Per Share (EPS)	-$1.88

Full Income Statement

Balance Sheet

The company has $203.72 million in cash and $8.72 million in debt, giving a net cash position of $195.01 million or $2.29 per share.

Cash & Cash Equivalents	203.72M
Total Debt	8.72M
Net Cash	195.01M
Net Cash Per Share	$2.29
Equity (Book Value)	219.74M
Book Value Per Share	3.09
Working Capital	193.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$115.01 million and capital expenditures -$1.36 million, giving a free cash flow of -$116.37 million.

Operating Cash Flow	-115.01M
Capital Expenditures	-1.36M
Free Cash Flow	-116.37M
FCF Per Share	-$1.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.91%
Shareholder Yield	-23.91%
Earnings Yield	-15.12%
FCF Yield	-13.24%

Analyst Forecast

The average price target for ORIC is $18.83, which is 82.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.83
Price Target Difference	82.64%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.69%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1